At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 180 enrolled
Drug / intervention
PEG-3350 group 2 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Tolerability of Low-volume Polyethylene Glycol (2 L) vs. Single- (4 L) vs. Split-dose (2L + 2L) of Polyethylene Glycol Bowel Preparation for Colonoscopy: a Randomized Clinical Trial.
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran·interventional·Posted Aug 28, 2013·Updated Aug 28, 2013
In Brief
A Phase 3 clinical trial evaluating PEG-3350 group 2, PEG-3350 group 1, and 1 other intervention for Bowel Preparation for Colonoscopy. Completed, enrolled 180 participants across 1 site.
Detailed Summary
the efficacy and tolerability of a low-volume (2 L) PEG regimen for colonoscopy compared to single (4 L) or split-dose (2 L + 2 L) treatments are not different.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBowel Preparation for Colonoscopy
CountriesMexico
Collaborators--
Timeline
Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
Primary CompletionJun 2012
First PostedAug 2013
TodayJul 2026
First PostedAug 28, 2013
Enrollment StartOct 1, 2011
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 12.8 years ago
Interventions
PEG-3350 group 2drug
split-dose (PEG-3350; 2 L the day before 17:00-19:00 h and 2 L same day of the procedure 06:00-08:00 am)
PEG-3350 group 1drug
PEG-3350; PEG-4 L the day previous of the study, starting at 17:00 and finishing at 21:00 h
PEG-3350 group 3drug
low-volume 2 L PEG-solution (same day of the procedure 06:00-08:00 am)